The Latest

We are pleased to announce our Rare Endocrine Disease (RED) Fellows Program designed to equip early career physicians with the knowledge and practical skills needed to improve outcomes for people living with rare endocrine diseases. This program was developed in partnership with the National Organization for Rare Disorders and addresses critical gaps in awareness, diagnosis, and care of rare endocrine diseases. Nominations have been extended to Friday, March 6.

This webinar will have three physicians who practice obesity medicine in three different settings, academia, private practice, and direct practice model. On Tuesday, March 24 at 5:00 PM ET, speakers will describe the current state of obesity medicine practice, including patient volumes, wait times, access to care, and differences between private practice and academic models. Register now.

Endocrine Self-Assessment (ESAP) 2026 delivers one hundred twenty new case-based questions that reflect real clinical practice and strengthen judgment. The program includes a comprehensive book, online learning, and a mobile app for flexible study. Earn up to 40 CME and MOC credits with expert authored, rigorously reviewed content. Start this year’s cases today and advance your practice.

Microscopy images offer a unique view into how hormones work. Showcase your lab’s best microscopy image by entering our Endocrine Images Art Competition. This year’s winners will be displayed at ENDO 2026. Submit your best light or electron microscopy image to the competition by March 13. The top images selected by our member volunteers will be featured on the Society’s website, magazine, and social media channels.

Host Aaron Lohr talks with Sara R. MacLeod, DO, MPH, of the University of Rochester; and Shannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN, of the University of Maryland School of Nursing, about the recently established Endocrinology Certificate for Advanced Practice Providers.

Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Andy Crawford, MD, from Dartmouth-Hitchcock Medical Center, and guest expert Giuseppe Barbesino, MD, from Harvard Medical School in Boston, about the paper "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease" by Miyamura et al., published in the August 2025 issue of JCEM.